Business Context and Reporting Period
This Form 8-K filing by Palisade Bio, Inc. (PALI) covers the date of September 26, 2025. The report addresses a corporate governance event regarding a special meeting of stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a procedural corporate event and contains no financial performance data.
Material Changes
The primary material event is the adjournment of the Company's special meeting of stockholders held on September 26, 2025. The meeting was adjourned without conducting business because a quorum was not achieved due to an insufficient number of shares present in person or by proxy.
Outlook, Management Commentary, and Risks
- Rescheduled Meeting: The adjourned special meeting is scheduled to reconvene on Friday, October 10, 2025, at 10:00 a.m. Pacific Time.
- Voting Record Date: The record date for determining stockholders entitled to vote remains July 28, 2025.
- Proposals: No changes have been made to the proposals to be voted on.
- Shareholder Action: Stockholders who have already voted do not need to take further action unless they wish to change their vote. Voting instructions remain available via the definitive proxy statement filed on August 18, 2025.
Key Facts for Investor Verification
- Verify the specific proposals listed in the Schedule 14A proxy statement filed on August 18, 2025, as these remain unchanged.
- Confirm the reconvened meeting date of October 10, 2025, and ensure voting mechanisms are accessible via the provided proxy platform.
- Note that the lack of a quorum on September 26, 2025, indicates potential challenges in shareholder engagement for this specific vote.